Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Search

Page Path

HOME
Search

Original Article

Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus

Hyun Young Woo, Jong Young Choi, Seung Kew Yoon, Dong Jin Suh, Seung Woon Paik, Kwang Hyub Han, Soon Ho Um, Byung Ik Kim, Heon Ju Lee, Mong Cho, Chun Kyon Lee, Dong Joon Kim, Jae Seok Hwang

Clin Mol Hepatol. 2014;20(2):168-176. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.168

View: 8058 Download: 61 Web of Science: 4 Crossref: 2

Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus

Yu Jin Kim, Jin Woo Lee, Yun Soo Kim, Sook-Hyang Jeong, Young Seok Kim, Hyung Joon Yim, Bo Hyun Kim, Chun Kyon Lee, Choong Kee Park, Sang Hoon Park

Clin Mol Hepatol. 2011;17(3):199-205. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.199

View: 7075 Download: 60 Crossref: 17

1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Impact Factor

8.9
First decision

09 Days

Publication after acceptance

04 Days

*Last 12 months

MOST VIEWED (Last 6 months)

Viewed By 5309	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5253	MAFLD: How is it different from NAFLD?
Viewed By 5155	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3867	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3806	Global incidence and prevalence of nonalcoholic fatty liver disease

+more

MOST CITED (2022-2024)

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

+more

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051 FAX: +82-2-703-0071 E-mail: kasl@kams.or.kr

COUNTER

TODAY : 1166

TOTAL : 1791972